CN112543629A - 外泌体胞外囊泡及其使用方法 - Google Patents

外泌体胞外囊泡及其使用方法 Download PDF

Info

Publication number
CN112543629A
CN112543629A CN201980042830.1A CN201980042830A CN112543629A CN 112543629 A CN112543629 A CN 112543629A CN 201980042830 A CN201980042830 A CN 201980042830A CN 112543629 A CN112543629 A CN 112543629A
Authority
CN
China
Prior art keywords
exosome
lnp
cell
cells
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980042830.1A
Other languages
English (en)
Chinese (zh)
Inventor
海迪·瓦拉迪
L·林福斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN112543629A publication Critical patent/CN112543629A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201980042830.1A 2018-06-28 2019-06-27 外泌体胞外囊泡及其使用方法 Pending CN112543629A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862691348P 2018-06-28 2018-06-28
US62/691348 2018-06-28
PCT/EP2019/067232 WO2020002540A1 (en) 2018-06-28 2019-06-27 Exosome extracellular vesicles and methods of use

Publications (1)

Publication Number Publication Date
CN112543629A true CN112543629A (zh) 2021-03-23

Family

ID=67139730

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980042830.1A Pending CN112543629A (zh) 2018-06-28 2019-06-27 外泌体胞外囊泡及其使用方法

Country Status (5)

Country Link
US (1) US12109310B2 (https=)
EP (1) EP3813798A1 (https=)
JP (2) JP2021528096A (https=)
CN (1) CN112543629A (https=)
WO (1) WO2020002540A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114848608A (zh) * 2022-05-17 2022-08-05 东南大学 一种蛋白或多肽递送载体及其制备方法与应用
CN115887758A (zh) * 2022-11-15 2023-04-04 西南交通大学 负载外泌体促进糖尿病创面修复的共聚水凝胶
CN117679354A (zh) * 2024-02-04 2024-03-12 知想(山东)医疗科技有限公司 含有γ-氨基丁酸的外泌体制剂及其制备方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11786607B2 (en) 2017-06-15 2023-10-17 Modernatx, Inc. RNA formulations
WO2019046809A1 (en) 2017-08-31 2019-03-07 Modernatx, Inc. METHODS OF MANUFACTURING LIPID NANOPARTICLES
CN113271926A (zh) 2018-09-20 2021-08-17 摩登纳特斯有限公司 脂质纳米颗粒的制备及其施用方法
KR20230167008A (ko) * 2020-08-06 2023-12-07 모더나티엑스, 인크. 지질 나노입자의 제조 방법
JP7633787B2 (ja) * 2020-09-23 2025-02-20 三洋化成工業株式会社 細胞外小胞の製造方法
JP2023546175A (ja) 2020-10-14 2023-11-01 ジョージ・メイソン・リサーチ・ファウンデーション・インコーポレイテッド 脂質ナノ粒子製造の方法及びそれに由来する組成物
WO2023178500A1 (en) * 2022-03-22 2023-09-28 Beijing Theraxyte Bioscience Co. Ltd. Therapeutic vesicles and methods of processing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130156849A1 (en) * 2011-12-16 2013-06-20 modeRNA Therapeutics Modified nucleoside, nucleotide, and nucleic acid compositions
US20160354313A1 (en) * 2014-01-21 2016-12-08 Anjarium Biosciences Ag Hybridosomes, compositions comprising the same, processes for their production and uses thereof
CN107530436A (zh) * 2015-01-21 2018-01-02 菲泽尔克斯公司 用于将治疗剂和诊断剂递送到细胞中的方法、组合物和系统
EP3292861A1 (en) * 2016-09-13 2018-03-14 Centre National De La Recherche Scientifique (Cnrs) An in vitro method for obtaining a biohybrid vector

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3569254B1 (en) * 2009-04-17 2022-07-20 Oxford University Innovation Limited Composition for delivery of genetic material
JP2010285426A (ja) * 2009-05-11 2010-12-24 National Cancer Center 核酸導入方法
MX342785B (es) 2009-06-10 2016-10-12 Alnylam Pharmaceuticals Inc Formulacion mejorada de lipido.
CA2805265A1 (en) 2010-08-02 2012-02-09 Merck Sharp & Dohme Corp. Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
US8691750B2 (en) 2011-05-17 2014-04-08 Axolabs Gmbh Lipids and compositions for intracellular delivery of biologically active compounds
SMT202200502T1 (it) 2014-06-25 2023-01-13 Acuitas Therapeutics Inc Nuovi lipidi e formulazioni di nanoparticelle lipidiche per l'erogazione di acidi nucleici
US20210290556A1 (en) * 2016-08-22 2021-09-23 Codiak Biosciences, Inc. Methods of suppressing delivery of exosomes to liver and spleen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130156849A1 (en) * 2011-12-16 2013-06-20 modeRNA Therapeutics Modified nucleoside, nucleotide, and nucleic acid compositions
US20160354313A1 (en) * 2014-01-21 2016-12-08 Anjarium Biosciences Ag Hybridosomes, compositions comprising the same, processes for their production and uses thereof
CN107530436A (zh) * 2015-01-21 2018-01-02 菲泽尔克斯公司 用于将治疗剂和诊断剂递送到细胞中的方法、组合物和系统
EP3292861A1 (en) * 2016-09-13 2018-03-14 Centre National De La Recherche Scientifique (Cnrs) An in vitro method for obtaining a biohybrid vector

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114848608A (zh) * 2022-05-17 2022-08-05 东南大学 一种蛋白或多肽递送载体及其制备方法与应用
CN114848608B (zh) * 2022-05-17 2024-01-30 东南大学 一种蛋白或多肽递送载体及其制备方法与应用
CN115887758A (zh) * 2022-11-15 2023-04-04 西南交通大学 负载外泌体促进糖尿病创面修复的共聚水凝胶
CN115887758B (zh) * 2022-11-15 2024-01-26 西南交通大学 负载外泌体促进糖尿病创面修复的共聚水凝胶
CN117679354A (zh) * 2024-02-04 2024-03-12 知想(山东)医疗科技有限公司 含有γ-氨基丁酸的外泌体制剂及其制备方法
CN117679354B (zh) * 2024-02-04 2024-05-28 知想(山东)医疗科技有限公司 金花茶外泌体制剂及其制备方法

Also Published As

Publication number Publication date
EP3813798A1 (en) 2021-05-05
JP2021528096A (ja) 2021-10-21
WO2020002540A1 (en) 2020-01-02
US20210315819A1 (en) 2021-10-14
JP2024081661A (ja) 2024-06-18
US12109310B2 (en) 2024-10-08

Similar Documents

Publication Publication Date Title
CN112543629A (zh) 外泌体胞外囊泡及其使用方法
JP7066632B2 (ja) 親油性抗炎症剤を含む脂質ナノ粒子およびその使用方法
US20250000797A1 (en) Nanomaterials
JP7186094B2 (ja) インターロイキン１７受容体ｍＲＮＡの特異的ノックダウンのためのアンチセンスオリゴヌクレオチド（ＡＳＯ）を提示するリポソーム系球状核酸（ＳＮＡ）構築物
JP2009221164A (ja) 肺線維症処置剤
JP5873419B2 (ja) 腸管線維症処置剤
EP3349730B1 (en) Systems for nucleic acid expression in vivo
US20240269318A1 (en) Nano-delivery systems comprising modified lipids and use thereof
CN120437322A (zh) 靶向载体、靶向药物及制备方法与应用
JP5914418B2 (ja) 脂質粒子、核酸送達キャリア、核酸送達キャリア製造用組成物、脂質粒子の製造方法及び遺伝子導入方法
CN117582510B (zh) 金属-多酚复合物在核酸递送系统中的应用
JP2023039115A (ja) 物質送達キャリア及び組成物
CN117582512B (zh) 金属-多酚复合物颗粒及其制备方法和应用
JP5517306B2 (ja) 肺線維症処置剤
WO2025226682A1 (en) Compositions containing milk small extracellular vesicles and lipid nanoparticles, and methods for their use
Lee et al. Bile Acid–Histidine Decapeptide Conjugates as Promising Additives in Lipid Nanoparticle Formulation for siRNA Delivery
Mun et al. Injured cardiac targeting magnetic nanovesicles for mRNA treatment of myocardial infarction
CN117582511A (zh) 金属-磷脂复合物颗粒及其制备方法与应用
CN117582417A (zh) 药物-脂质颗粒及其制备方法和应用
KR20260043575A (ko) 선택적 장기 표적 지질을 포함하는 조성물
WO2026007662A1 (zh) 一种靶向肝实质细胞的核酸递送载体及其应用
HK1213812A1 (zh) 包含m10c1化合物与活性成分的组合物及其制备方法
JP5976874B2 (ja) 肺線維症処置剤
CN117582407A (zh) 金属-磷脂复合物及其制备方法与应用
CN117582416A (zh) 药物-脂质颗粒及其制备方法和应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination